Literature DB >> 10543676

Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation.

Y C Ong, H B Wong, G Adaikan, E L Yong.   

Abstract

We report a 46,XY infant with an M807T mutation in his androgen receptor that abrogated cellular responses to testosterone, but not to dihydrotestosterone (DHT), resulting in ambiguous genitalia. Treatment with a topical DHT gel restored male genital development allowing the infant to be reared in accordance with his chromosomal sex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543676     DOI: 10.1016/s0140-6736(99)03205-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  Gender Incongruity in a Person with 46,XY and Complete Androgen Insensitivity Syndrome Raised as a Female.

Authors:  Diego Jesús Del Can Sánchez; Suset Dueñas Disotuar; Ana Piñar Gutiérrez; Miguel Ángel Japón Rodríguez; Isabel Olea Comas; Alejandro Déniz García; Alfonso Soto Moreno; Miguel Ángel Mangas Cruz
Journal:  Arch Sex Behav       Date:  2021-11-16

Review 2.  Micropenis: etiology, diagnosis and treatment approaches.

Authors:  Nihal Hatipoğlu; Selim Kurtoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.